A review of topotecan in combination chemotherapy for advanced cervical cancer

References

• Abu-RustumNRLeeSMassadLSTopotecan for recurrent cervical cancer after platinum-based therapyInt J Gynecol Cancer200010285811240688
   PubMed Web of Science ®Google Scholar
• BellMCDavidsonSAMathisJMTopotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trialGynecol Oncol2001801283111161849
   PubMed Web of Science ®Google Scholar
• BelozerovVEVan MeirEGHypoxia inducible factor-1: a novel target for cancer therapyAnticancer Drugs200516901916162966
   PubMed Web of Science ®Google Scholar
• BerekJSHackerNFPractical Gynecologic Oncology US20054Philadelphia, PALippincott Williams and Wilkins3856
   Google Scholar
• BookmanMABlessingJAHanjaniPTopotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupGynecol Oncol200077446910831357
   PubMed Web of Science ®Google Scholar
• BraveMDagherRFarrellATopotecan in combination with Cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancerOncology (Williston park)20062014011117112001
   PubMed Web of Science ®Google Scholar
• BrewerCABlessingJANagourneyRACisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupGynecol Oncol2006100385816271750
   PubMed Web of Science ®Google Scholar
• ChoiCHKimTJLeeSJSalvage chemotherapy with a combination of paclitaxel, ifosfamide, and Cisplatin for the patients with recurrent carcinoma of the uterine cervixInt J Gynecol Cancer20061611576416803500
   PubMed Web of Science ®Google Scholar
• DuntonCJKingSANeufeldJRNPhase I study of topotecan and radiation therapy in advanced cervical cancerGynecol Oncol200285185711925142
   PubMed Web of Science ®Google Scholar
• DuPontNCMonkBJChemotherapy in the management of cervical carcinomaClin Adv Hematol Oncol20064279616728939
   PubMedGoogle Scholar
• FioricaJVThe role of topotecan in the treatment of advanced cervical cancerGynecol Oncol200390S162113129491
   PubMed Web of Science ®Google Scholar
• FioricaJHollowayRNdubisiBPhase II trial of topotecan and Cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervixGynecol Oncol200285899411925125
   PubMed Web of Science ®Google Scholar
• HochsterHLeibesLSpyerJPhase I trial of low dose continuous topotecan infusion in patients with cancer; an active and well-tolerated regimenJ Clin Oncol19941255398120553
   PubMed Web of Science ®Google Scholar
• KeysHMBundyBNStehmanFBCisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinomaN Engl J Med199934011546110202166
   PubMed Web of Science ®Google Scholar
• LingYHDonatoNJPerez-SolerRSensitivity to topoisomerase I inhibitors and Cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME 180 sublinesCancer Chemother Pharmacol2001474738011459199
   PubMed Web of Science ®Google Scholar
• LongHJ3rdBundyBnGrendysECJRRandomized phase III trial of Cisplatin with or without topotecan in carcinoma of the uterine cervix: a gynecologic oncology group studyJ Clin Oncol200523462333
   Web of Science ®Google Scholar
• MainwaringPNNicolsonMCHickishTContinuous infusional topotecan in advanced breast and non-small cell lung cancer; no evidence of increased efficacyBr J Cancer199776163699413954
   PubMed Web of Science ®Google Scholar
• MalufFCLeiserAlAghajanianCPhase II study of tirapazamine plus Cisplatin in patients with advanced or recurrent cervical cancerInt J Gynecol Cancer20061611657116803501
   PubMed Web of Science ®Google Scholar
• MannelRSBlessingJABoikeGCisplatin and pentoxiyilline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncolology GroupGynecol Oncol20007964611006033
   PubMed Web of Science ®Google Scholar
• MonkBJHuangHQCellaDQuality of life outcomes from a randomized phase III trial of Cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group StudyJ Clin Oncol20052346172515911864
   PubMed Web of Science ®Google Scholar
• MooreDHBlessingJAMcQuellonRPPhase III study of Cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group studyJ Clin Oncol2004223113915284262
   PubMed Web of Science ®Google Scholar
• MorrisMEifelPJLuJPelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancerN Engl J Med199934011374310202164
   PubMed Web of Science ®Google Scholar
• MuderspachLIBlessingJALevenbackCphase II study of topotecan in patients with squamous cell carcinoma of the cervix: A Gynecologic Oncology Group StudyGynecol Oncol200181213111354055
   PubMed Web of Science ®Google Scholar
• MuggiaFMBlessingJAMc GeheeRCisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecology Oncology GroupGynecol Oncol200494483715297192
   PubMed Web of Science ®Google Scholar
• NodaKSasakiHYamamotoTPhase II trial of topotecan for cervical cancer of uterus (abstract)Proc Am Soc Clin Oncol199615280
   Google Scholar
• OhwadaMMashidaSFujiwaraHPhase II study of combination chemotherapy using irinotecan and nedaplatin for patients with primary advanced or recurrent cervical cancer (abstract)J Clin Oncol2004225088
   Google Scholar
• OmuraGABlessingJAVaccarelloLRandomized trial of Cisplatin versus Cisplatin plus mitolactol versus Cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a gynecologic oncology group studyJ Clin Oncol199715165718996138
   PubMed Web of Science ®Google Scholar
• PetersWAIIILiuPYBarrettRJIIConcurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixJ Clin Oncol20001816061310764420
   PubMed Web of Science ®Google Scholar
• PohlmannPDileoneLPCancellaAIPhase II trial of Cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervixAm J Clin Oncol20022549650112393992
   PubMed Web of Science ®Google Scholar
• Randall-WhitisLMMonkBJTopotecan in the management of cervical cancerExpert Opin Pharmacother200782273617257092
   PubMed Web of Science ®Google Scholar
• RosePGBundyBNWatkinsEBConcurrent Cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancerN Engl J Med199934011445310202165
   PubMed Web of Science ®Google Scholar
• RowinskyEKVerweijJReview of phase I clinical studies with topotecanSemin Oncol199724Suppl 20S203S2010
   Google Scholar
• SaslowDCastlePECoxTAmerican Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsCA Cancer J Clin20075772817237032
   PubMed Web of Science ®Google Scholar
• SerkiesKJassemJdziadziuskoRChemotherapy with mitomycin C, ifosfamide, and Cisplatin for recurrent or persistent cervical cancerInt J Gynecol Oncol20061611526
   PubMed Web of Science ®Google Scholar
• TierstenADSelleckMJHershmanDLPhase II study of topotecan and paclitaxel for persistent, or metastatic cervical cancerGynecol Oncol200492635814766258
   PubMed Web of Science ®Google Scholar
• van WarmerdamLJten Bokkel HuininkWWRodenhuisSPhase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionJ Clin Oncol1995131768767602366
   PubMed Web of Science ®Google Scholar
• WhitneyCWSauseWBundyBNRandomized comparison of fluorouracil plus Cisplatin versus hydroxyuria as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a GOG and SWOG studyJ Clin Oncol19991713395510334517
   PubMed Web of Science ®Google Scholar
• ZanettaGFeiFParmaGPaclitaxel, ifosfamide and Cisplatin (TIP) chemotherapy for recurrent or persistent squamous- cell cervical cancerAnn Oncol1999101171410586332
   PubMed Web of Science ®Google Scholar